Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For

See also
Status	Clinical Trial	Phase
Completed	`NCT04924036` - Qbrexza Cloths for Hyperhidrosis of Amputation Sites	Phase 2
Recruiting	`NCT05102396` - Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?	Phase 2
Recruiting	`NCT04178161` - Image Guided Targeted Photoablation for the Treatment of Localized Hyperhidrosis	N/A
Completed	`NCT02552199` - A Non-Interventional Study To Assess Sweating
Completed	`NCT02565732` - Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis	Phase 2
Recruiting	`NCT01930604` - Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis	Phase 2
Completed	`NCT01671800` - Study to Assess the Efficacy of Botulinum Toxin B (Myobloc) for the Treatment of Prosthesis-associated Sweating	Phase 1
Completed	`NCT01956591` - Long Term Results of the Use of Oxybutynin for the Treatment of Hyperhidrosis	N/A
Completed	`NCT01934153` - Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects	Phase 1
Completed	`NCT06113978` - Thoracoscopic Sympathetic Chain Interruption for Palmar Hyperhidrosis in Patients Below 18	N/A
Completed	`NCT04906655` - An Open Label Study for Palmar Hyperhydrosis	Phase 2
Completed	`NCT05247333` - Implementation of a Minor Ailment Service in Community Pharmacy Practice	N/A
Completed	`NCT02563899` - Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis	Phase 2
Withdrawn	`NCT05546710` - miraDry Post Market Tumescent Anesthesia Study	N/A
Completed	`NCT02016885` - A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis	Phase 2
Completed	`NCT00168480` - A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis	Phase 4
Completed	`NCT03416348` - Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2	Phase 1
Completed	`NCT02973659` - The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar.	N/A
Recruiting	`NCT05805696` - Treatment and Mapping of Impostor Phenomenon	N/A
Completed	`NCT03816046` - Hyperhydrosis Treatment Using Botulinum Toxin	Phase 4

NCT number	NCT01811004
Study type	Interventional
Source	Cynosure, Inc.
Contact
Status	Completed
Phase	N/A
Start date	September 2012
Completion date	July 2015

Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms